The monoclonal antibody therapeutics market has advanced significantly in the past few years owing to rising demand for targeted therapies to treat chronic diseases. Monoclonal antibodies are artificially produced antibodies that are tailored to target specific proteins expressed by disease-causing cells. They can be designed to target cell-surface receptors or soluble molecules and inhibit...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian